{"url_path":"/sec/kphmw/10-q/2026/item-5","section_key":"item-5","section_title":"Item 5 Other Information.","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-08","source_url":"https://www.sec.gov/Archives/edgar/data/1372514/0001372514-26-000047-index.html","accession_number":"0001372514-26-000047","cik":"0001372514","ticker":"KPRX","issuer_name":"KIORA PHARMACEUTICALS INC","edgar_url":"https://www.sec.gov/Archives/edgar/data/1372514/0001372514-26-000047-index.html","primary_entity_key":"0001372514","primary_entity_name":"KIORA PHARMACEUTICALS INC"},"word_count":43,"has_tables":true,"body_markdown":"Item 5. Other Information.\n\nNo officers or directors, as defined in Rule 16a-1(f), adopted, modified or terminated a Rule 10b5-1 trading arrangement or a non-Rule 10b5-1 trading arrangement as defined in item 408 of Regulation S-K, during the period ended March 31, 2026."}